HE Siyi 1,2,3,4,5 , LIU Jianing 1,2,3,4,6,7 , LI Hailong 1,2,3,4 , ZENG Linan 1,2,3,4 , HAN Lu 1,2,3,4,5 , BO Zhenyan 1,2,3,4,7 , YI Qiusha 1,2,3,4 , ZOU Kun 1,2,3,4 , ZHANG Lingli 1,2,3,4,7
  • 1. Department of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu 610041, P. R. China;
  • 2. Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu 610041, P. R. China;
  • 3. NMPA Key Laboratory for Technical Research on Drug Products in vitro and in vivo Correlation, Chengdu 610041, P. R. China;
  • 4. Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu 610041, P. R. China;
  • 5. West China School of Pharmacy, Sichuan University, Chengdu 610041, P. R. China;
  • 6. West China School of Medicine, Sichuan University, Chengdu 610041, P. R. China;
  • 7. Chinese Evidence-based Medicine Center, West China Hospital, Sichuan University, Chengdu 610041, P. R. China;
ZOU Kun, Email: kun.zou@scu.edu.cn; ZHANG Lingli, Email: zhanglingli@scu.edu.cn
Export PDF Favorites Scan Get Citation

Objective To systematically review the classification system for the causes of pediatric drug shortages in China, and classify the causes of pediatric drug shortages accurately, so as to provide references for the formulation of targeted strategies. Methods Four databases including Embase, PubMed, CBM and CNKI were searched from inception to November 2023. Quantitative research, qualitative research and mixed-method research on the causes of pediatric drug shortages in China were included. Two researchers independently screened the literature and extracted data. Based on the theory of efficient market and effective government, and according to the life cycle of the drug supply chain, the fundamental causes of drug shortages were classified and summarized by thematic synthesis. Results Fourteen articles were included. According to the four stages of the drug supply chain (research and development, production, circulation and use), a total of 19 categories of causes of the pediatric drug shortages were summarized, including 5 categories in the research and development stage, 4 categories in the production stage, 6 categories in the circulation stage, and 4 categories in the use stage. Based on the theory of efficient market and effective government, further analysis of the causes revealed that the identified reasons could be attributed to three major fundamental causes: market failure, government failure, and other causes. Among them, 6 categories were related to market failure, 7 categories were related to government failure, and 6 categories were classified as other causes. Conclusion Based on the theory of efficient market and effective government, this study established a classification system of fundamental causes of the pediatric drug shortages, and made policy suggestions accordingly. Subsequently, the classification system established in this study can be used as references to develop targeted strategies to solve the problem of pediatric drug shortages in the life cycle of drug supply chain from government and market perspectives.

Citation: HE Siyi, LIU Jianing, LI Hailong, ZENG Linan, HAN Lu, BO Zhenyan, YI Qiusha, ZOU Kun, ZHANG Lingli. Classification system of the causes of pediatric drug shortages in China: a systematic review. Chinese Journal of Evidence-Based Medicine, 2024, 24(9): 1030-1037. doi: 10.7507/1672-2531.202402022 Copy

  • Previous Article

    Methodological guidelines for health technology assessment: a systematic review
  • Next Article

    Predictive model for the risk of knee osteoarthritis: a systematic review